News for Healthier Living

Drug Candidate Successfully Treats Atherosclerosis, Fatty Liver Disease in Large Mammals

A drug candidate previously successful at treating severe fatty liver disease, reduces atherosclerosis in large mammals, a study suggests. The compound, DT-109, presents as a dual-action drug capable of treating both metabolic dysfunction-associated steatotic liver disease (MASH) and the vascular complications associated with atherosclerosis, a significant advancement in the treatment landscape.

April 22, 2025


December 16 2025

December 15 2025

December 14 2025

December 13 2025

December 12 2025

December 11 2025

December 10 2025

December 9 2025

December 8 2025

December 7 2025

December 6 2025

December 5 2025

December 4 2025

December 3 2025

December 2 2025